Showing results (331-340 of 438) with videos related to

Sort By:
Pageof 44
The American Journal of Medicine|August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)Rohan Shah, Robert M Clare, Karen Chiswell, et al.
The American Journal of Cardiology|May 12, 2007
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Anita Y Chen, et al.
Journal of Thrombosis and Thrombolysis|February 21, 2020
Patients with acute and chronic coronary syndromes have elevated long-term thrombin generationChristina Yip, Aruni Seneviratna, Sock-Hwee Tan, et al.
The Journal of Invasive Cardiology|November 11, 2003
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main resultsKenneth W Mahaffey, Bruce E Lewis, Nancy M Wildermann, et al.
Journal of the American Heart Association|May 27, 2022
Cangrelor Use Patterns and Transition to Oral P2Y<sub>12</sub> Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO RegistryJennifer A Rymer, Deepak L Bhatt, Dominick J Angiolillo, et al.
American Heart Journal|March 21, 2016
Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trialLouis P Kohl, Jeffrey D Leimberger, Karen Chiswell, et al.
Journal of the American College of Cardiology|April 4, 2006
ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction?Timothy D Henry, James M Atkins, Michael S Cunningham, et al.
American Heart Journal|September 21, 2015
Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trialPeter Clemmensen, Matthew T Roe, Judith S Hochman, et al.
American Heart Journal|July 1, 2008
Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitalsMatthew T Roe, Anita Y Chen, Elizabeth R Delong, et al.
European Journal of Preventive Cardiology|August 7, 2013
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosisJacob A Udell, Ph Gabriel Steg, Benjamin M Scirica, et al.
Pageof 44